{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:31:56Z","timestamp":1784698316623,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>To determine the effect of various factors to the preservation rate of the conjunctival layer borderlines of glaucomatous eyes treated with anti-glaucoma eye drops.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Anterior segment optical coherence tomography (AS-OCT) images of the bulbar conjunctiva of 328 eyes were analyzed with and without anti-glaucoma eye drops to quantify the preservation rates of the conjunctival layer borderlines.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>More anti-glaucoma eye drops and a longer duration of administration were associated with lower preservation rates of the borderlines between both the conjunctival stroma\/Tenon\u2019s capsule (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001 and <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, respectively) and Tenon\u2019s capsule\/sclera (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001 and <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, respectively). Prostaglandin analogs and fixed combinations of \u03b2-blockers\/prostaglandin analogs were prognostic factors for lower preservation rates of the borderlines between both the conjunctival stroma\/Tenon\u2019s capsule (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001 and <jats:italic>P<\/jats:italic>\u00a0=\u20090.009, respectively) and Tenon\u2019s capsule\/sclera (<jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001 and <jats:italic>P<\/jats:italic>\u00a0=\u20090.008, respectively).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Numerous anti-glaucoma eye drops and their long-term administration are associated with the disruption of the bulbar conjunctival borderlines detected by AS-OCT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01518-6","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T11:03:52Z","timestamp":1592564632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Conjunctival structure of glaucomatous eyes treated with anti-glaucoma eye drops: a cross-sectional study using anterior segment optical coherence tomography"],"prefix":"10.1186","volume":"20","author":[{"given":"Makoto","family":"Gozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Inatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"1518_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","volume":"114","author":"B Bengtsson","year":"2007","unstructured":"Bengtsson B, Leske MC, Hyman L, Heijl A. Early manifest Glaucoma trial group. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:205\u20139.","journal-title":"Ophthalmology"},{"key":"1518_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"DR Anderson","year":"1998","unstructured":"Anderson DR, Drance SM, Schulzer M. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 1998;126:487\u201397.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1518_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u201313 discussion 829-30.","journal-title":"Arch Ophthalmol"},{"key":"1518_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajo.2006.02.056","volume":"142","author":"S Hong","year":"2006","unstructured":"Hong S, Lee CS, Seo KY, Seong GJ, Hong YJ. Effects of topical antiglaucoma application on conjunctival impression cytology specimens. Am J Ophthalmol. 2006;142:185\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1518_CR5","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1167\/iovs.04-1331","volume":"46","author":"JM Guenoun","year":"2005","unstructured":"Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:2444\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1167\/iovs.03-1067","volume":"45","author":"P-J Pisella","year":"2004","unstructured":"Pisella P-J, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci. 2004;45:1360\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR7","first-page":"264","volume":"130","author":"JM De Saint","year":"2000","unstructured":"De Saint JM, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. Am J Ophthalmol. 2000;130:264\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1518_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1442-9071.2003.00760.x","volume":"32","author":"AS Do\u011fan","year":"2004","unstructured":"Do\u011fan AS, Orhan M, S\u00f6ylemezo\u011flu F, Irke\u00e7 M, Bozkurt B. Effects of topical antiglaucoma drugs on apoptosis rates of conjunctival epithelial cells in glaucoma patients. Clin Exp Ophthalmol. 2004;32:62\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"1518_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/BF00166608","volume":"233","author":"R Nuzzi","year":"1995","unstructured":"Nuzzi R, Vercelli A, Finazzo C, Cracco C. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233:154\u20132.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1518_CR10","first-page":"35","volume":"48","author":"A Nenciu","year":"2004","unstructured":"Nenciu A, Stefan C, Ardelean C. Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication. Oftalmologia. 2004;48:35\u201342.","journal-title":"Oftalmologia"},{"key":"1518_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","volume":"112","author":"DC Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. the conjunctival cell profile. Arch Ophthalmol. 1994;112:1437\u201345.","journal-title":"Arch Ophthalmol"},{"key":"1518_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","volume":"96","author":"MB Sherwood","year":"1989","unstructured":"Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients. Ophthalmology. 1989;96:327\u201335.","journal-title":"Ophthalmology"},{"key":"1518_CR13","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1167\/iovs.11-7749","volume":"52","author":"X Zhang","year":"2011","unstructured":"Zhang X, Li Q, Liu B, Zhou H, Wang H, Zhang Z, et al. In vivo cross-sectional observation and thickness measurement of bulbar conjunctiva using optical coherence tomography. Invest Ophthalmol Vis Sci. 2011;52:7787\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/aos.13071","volume":"94","author":"M Gozawa","year":"2016","unstructured":"Gozawa M, Takamura Y, Miyake S, Yokota S, Sakashita M, Arimura S, et al. Prospective observational study of conjunctival scarring after phacoemulsification. Acta Ophthalmol. 2016;94:541\u20139.","journal-title":"Acta Ophthalmol"},{"key":"1518_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/aos.13459","volume":"95","author":"M Gozawa","year":"2017","unstructured":"Gozawa M, Takamura Y, Miyake S, Iwasaki K, Arimura S, Takihara Y, et al. Comparison of subconjunctival scarring after microincision vitrectomy surgery using 20-, 23-, 25- and 27-gage systems in rabbits. Acta Ophthalmol. 2017;95:602\u20139.","journal-title":"Acta Ophthalmol"},{"key":"1518_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/IJG.0b013e31818153f4","volume":"18","author":"MD Rodrigues","year":"2009","unstructured":"Rodrigues MD, Crosta DP, Soares CP, Deghaide NH, Duarte R, Sakamoto FS, et al. Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment. J Glaucoma. 2009;18:197\u2013200.","journal-title":"J Glaucoma"},{"key":"1518_CR17","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1167\/iovs.18-24013","volume":"59","author":"Y Yang","year":"2018","unstructured":"Yang Y, Huang C, Lin X, Wu Y, Ouyang W, Tang L, et al. 0.005% preservative-free Latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice. Invest Ophthalmol Vis Sci. 2018;59:3375\u201384.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1167\/iovs.05-0902","volume":"47","author":"T Ito","year":"2006","unstructured":"Ito T, Ohguro H, Mamiya K, Ohguro I, Nakazawa M. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue. Invest Ophthalmol Vis Sci. 2006;47:823\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR19","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1167\/iovs.02-0462","volume":"44","author":"H Mietz","year":"2003","unstructured":"Mietz H, Esser JM, Welsandt G, Kociok N, Hueber A, Joussen A, et al. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Invest Ophthalmol Vis Sci. 2003;44:5182\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1518_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bjo.2008.140186","volume":"93","author":"N Terai","year":"2009","unstructured":"Terai N, Schl\u00f6tzer-Schrehardt U, Lampel J, B\u00f6hm AG, Rummelt C, Schmidt E, et al. Effect of latanoprost and timolol on the histopathology of the human conjunctiva. Br J Ophthalmol. 2009;93:219\u201324.","journal-title":"Br J Ophthalmol"},{"key":"1518_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1089\/jop.2015.0067","volume":"31","author":"HY Shin","year":"2015","unstructured":"Shin HY, Lee HS, Lee YC, Kim SY. Effect of Brimonidine on the B cells, T cells, and cytokines of the ocular surface and aqueous humor in Rat eyes. J Ocul Pharmacol Ther. 2015;31:623\u20136.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1518_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","volume":"23","author":"RJ Noecker","year":"2004","unstructured":"Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490\u20136.","journal-title":"Cornea"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01518-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T23:28:04Z","timestamp":1624058884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1518"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01518-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"10 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective, observational, and cross-sectional study was approved by the Institutional Review Board of the University of Fukui Hospital, Fukui, Japan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}